Innate Pharma SA (IPHA)
NASDAQ
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Return on Assets (%) | 4.303 | -18.034 | 0.863 | -4.87 | -18.055 | -18.371 | -24.446 | -3.862 |
Return on Equity (%) | 15.976 | -56.221 | 2.408 | -10.794 | -34.272 | -40.096 | -71.914 | -14.276 |
Return on Invested Capital (%) | 22.391 | -84.138 | 14.805 | -7.938 | -1.194 | -76.644 | -28.32 | -23.208 |
Operating Margin (%) | 19.96 | -107.601 | 9.131 | -29.801 | -110.46 | -376.682 | -111.987 | -13.352 |
Net Profit Margin (%) | 19.233 | -109.883 | 3.816 | -30.097 | -112.582 | -379.593 | -116.682 | -14.585 |
Book Value Per Share | 1.43 | 0.69 | 1.294 | 1.528 | 1.388 | 0.795 | 0.656 | 0.637 |
Earnings Per Share | 0.234 | -0.84 | 0.048 | -0.263 | -0.81 | -0.664 | -0.724 | -0.094 |
Cash Per Share | 3.262 | 1.725 | 2.382 | 2.574 | 1.732 | 1.304 | 1.05 | 0.873 |
Working Capital Per Share | 2.856 | 1.104 | 1.922 | 1.469 | 1.62 | 0.734 | 1.228 | 1.34 |
Operating Profit Per Share | 0.632 | 0.69 | 1.47 | 1.079 | 0.864 | 0.295 | 0.715 | 0.759 |
EBIT Per Share | 0.24 | -0.834 | 0.042 | -0.263 | -0.81 | -0.664 | -0.724 | -0.094 |
EBITDA Per Share | 0.24 | -0.834 | 0.042 | -0.263 | -0.81 | -0.664 | -0.724 | -0.094 |
Free Cash Flow Per Share | 0.199 | -0.865 | -0.053 | -0.457 | -0.967 | -0.707 | -0.772 | -0.152 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 53,92M | 57,6M | 63,93M | 78,81M | 78,99M | 79,54M | 80,21M | 80,86M |
Fin d'année 31 Décembre 2023 | ||||||||
---|---|---|---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Actions en circulation | N/A | |||||||
Return on Assets (%) | N/A | |||||||
Return on Equity (%) | N/A | |||||||
Return on Invested Capital (%) | N/A | |||||||
Operating Margin (%) | N/A | |||||||
Net Profit Margin (%) | N/A | |||||||
Sales Per Share | N/A | |||||||
Book Value Per Share | N/A | |||||||
Earnings Per Share | N/A | |||||||
Cash Per Share | N/A | |||||||
Working Capital Per Share | N/A | |||||||
Operating Profit Per Share | N/A | |||||||
EBIT Per Share | N/A | |||||||
EBITDA Per Share | N/A | |||||||
Free Cash Flow Per Share | N/A | |||||||
Current Ratio | N/A | |||||||
Quick Ratio | N/A | |||||||
Inventory Turnover (Days) | N/A |
Capitalisation boursière | 124,7M |
Ratio cours/bénéfice | -20,19 |
Ratio prix/ventes | 2,48 |
Ratio prix/liquidités | 2,16 |
Ratio prix/valeur comptable | 2,95 |
Rendement de dividende | - |
Actions en circulation | 80,45M |
Volume moyen (1 semaine) | 0 |
Volume moyen (1 mois) | 0 |
Variation sur 52 semaines | - |
Plus haut sur 52 semaines | - |
Plus bas sur 52 semaines | - |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales